Frontlight ResearchEarly access
Active, not recruitingNo phase
Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)
Key facts
- Who runs it
- Apifix
- Where
- Atlanta, Charlottesville, Cleveland, Columbia, Dayton, Indianapolis, Jackson, Jacksonville, Kansas City, New York, Rochester, San Diego, Sioux Falls, and St Louis, United StatesSee the 14 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 201 people enrolled
- Started
- 31 May 2020
- Expected to end
- 30 Jun 2030
- Type of study
- Interventional
- Treatments tested
- MID-C System
- Record updated
- 3 October 2025
Who can take part
- Age
- 10 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Adolescent Idiopathic Scoliosis classified as Lenke Type 1 or Type 5 curves
- Cobb angle between 35-60 degrees (inclusive)
- Flexible curve that that reduces to ≤ 30 degrees on lateral side-bending radiographs or as evident by traction x-ray
- Kyphosis angles of ≤ 55 degrees measured from T5 to T12
- Appropriate candidate for posterior surgical approach
- Patient has good general health
- Patient has no known hypersensitivity or allergies to titanium
- Patient's guardian signs a written informed consent form (ICF)
Who cannot take part
- Previous spine surgery that would prevent the successful performance of the MID-C system
- Known history of existing malignancy, or any systemic or local infection
- Active systemic disease, such as AIDS, HIV, or active infection
- Active infection or the skin is compromised at the surgical site
- Systemic disease that would affect the Patient's welfare or overall outcome of the study
- Any type of non-idiopathic scoliosis
- Any main thoracic deformity that includes vertebral levels and cranial including to T2
- Spinal cord abnormalities that require treatment
- Known neurological deficit (defined as motor grade < 5/5)
- Known poor bone quality defined as T score -1.5 or less
- For female Patient, pregnancy
Where in United States
- WellstarAtlanta, United States
- University of VirginiaCharlottesville, United States
- Rainbow babies and childrenCleveland, United States
- Women and Children's Hospital - University of Missouri Health CareColumbia, United States
- Dayton Children's HospitalDayton, United States
- Riley Children's HealthIndianapolis, United States
- Univ. of Mississippi Medical Center (UMMC)Jackson, United States
- Wolfson Children's HospitalJacksonville, United States
- Children's Mercy HospitalKansas City, United States
- Mount Sinai HospitalNew York, United States
- Mayo ClinicRochester, United States
- Rady Children's HospitalSan Diego, United States
- Avera HealthSioux Falls, United States
- Shriners Hospitals for ChildrenSt Louis, United States
About the trial
What the trial wants to find out
The ApiFix MID-C System is a unidirectional expandable rod, designed to be connected unilaterally to the spine via 2 anchor points on the concave side of a scoliotic deformity above and below the apex of the major curvature to treat adolescent idiopathic scoliosis. The MID-C System is designed to act as an internal brace. Patients implanted with the device in the US within 2 years of FDA's approval of H17001 should be enrolled in the study. A minimum number of 200 patients will be enrolled in this study.
The group in the trial
- MID-C treatmentTreatment being tested
Treatment: MID-C System
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 3 October 2025